HIGHLIGHTS
- who: Jesus Guzman et al. from the Universidad Peruana Cayetano Heredia (UPCH), Lima, Peru have published the paper: Anti-Helicobacter pylori Properties of the Ant-Venom Peptide Bicarinalin, in the Journal: Toxins 2018, 10, 21 of /2018/
- what: The authors investigate the potential of as a novel agent against Helicobacter pylori which causes several gastric diseases. In recent years, the overuse of this therapeutic strategy has promoted the emergence of antibiotic resistant strains, and antibiotic resistance is now the main reason for treatment failure. The authors demonstrate that H. pylori strains isolated from Peruvian patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.